J Gerontol Ser A
Use of GLP-1RAs is appropriate in several patient groups, including patients whose HbA1c is uncontrolled, especially if this is due to postprandial glucose excursions and patients who are overweight or obese due to dietary problems (e.g., appetite control)
Cardiovascular Relating to the heart and blood vessels
Khi mua hng, lun kim tra cc thng tin trn trnh mua phi hng gi, hng nhi
If the patient enrolled in a commercial weight-loss program (Weight Watchers, Noom, Jenny Craig, or a hospital-based program), the provider must submit: Enrollment confirmation with start date Attendance or participation logs showing at least 90 days of engagement Documentation that the program did not result in sustained weight loss (defined as less than 5% body weight reduction) Option 3: Bariatric counseling visit notes
Participants taking retatrutide 4 mg, 9 mg, and 12 mg lost an average of 29.8 lbs (12.7%), 45.4 lbs (19.1%), and 49.6 lbs (20.8%), respectively, HbA1C was reduced of up to an average of 1.6% with retatrutide